In this podcast, Contributing Editor Dr. Brad Kahl has a conversation with Dr. Mark Roschewski. They discuss Dr. Kahl's Diffusion article from the November/December 2020 issue of The Hematologist, titled, "Is Dose-adjusted EPOCH-R Enough in Burkitt Lymphoma?" They discuss a study that evaluates the efficacy of the dose-adjusted EPOCH-R regimen in adult patients with Burkitt lymphoma. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/472152/Is-Dose-adjusted-EPOCH-R-Enough-in-Burkitt.

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/